Jim Simons Chroma Dex Corp. Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Chroma Dex Corp. stock. As of the latest transaction made, Renaissance Technologies LLC holds 424,200 shares of CDXC stock, worth $3.16 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

424,200

Previous 416,100 1.95%

Holding current value

$3.16 Million

Previous $1.14 Million 36.39%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$2.51 - $3.8 $20,331 - $30,780	8,100 Added 1.95%	424,200 $1.55 Million
Q2 2024 Aug 09, 2024	BUY	$2.44 - $4.32 $79,056 - $139,968	32,400 Added 8.44%	416,100 $1.14 Million
Q1 2024 May 13, 2024	SELL	$1.36 - $3.84 $116,418 - $328,711	-85,602 Reduced 18.24%	383,700 $1.34 Million
Q4 2023 Feb 13, 2024	BUY	$1.28 - $1.6 $31,219 - $39,024	24,390 Added 5.48%	469,302 $671,000
Q3 2023 Nov 14, 2023	SELL	$1.36 - $1.77 $21,252 - $27,659	-15,627 Reduced 3.39%	444,912 $650,000
Q2 2023 Aug 11, 2023	BUY	$1.31 - $1.79 $43,674 - $59,676	33,339 Added 7.8%	460,539 $723,000
Q1 2023 May 12, 2023	SELL	$1.48 - $2.19 $212,676 - $314,703	-143,700 Reduced 25.17%	427,200 $654,000
Q4 2022 Feb 13, 2023	SELL	$1.25 - $1.94 $59,137 - $91,781	-47,310 Reduced 7.65%	570,900 $959,000
Q3 2022 Nov 14, 2022	SELL	$1.19 - $2.06 $144,811 - $250,681	-121,690 Reduced 16.45%	618,210 $760,000
Q2 2022 Aug 12, 2022	BUY	$1.59 - $2.7 $507,844 - $862,377	319,399 Added 75.96%	739,900 $1.24 Million
Q1 2022 May 13, 2022	BUY	$2.02 - $3.92 $772,474 - $1.5 Million	382,413 Added 1004.02%	420,501 $1.03 Million
Q4 2021 Feb 11, 2022	BUY	$3.74 - $6.7 $142,449 - $255,189	38,088 New	38,088 $142,000
Q1 2021 May 13, 2021	SELL	$4.59 - $18.74 $1.08 Million - $4.41 Million	-235,200 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$3.93 - $5.5 $604,508 - $846,004	153,819 Added 189.01%	235,200 $1.13 Million
Q3 2020 Nov 13, 2020	SELL	$4.01 - $5.56 $516,564 - $716,233	-128,819 Reduced 61.28%	81,381 $326,000
Q2 2020 Aug 13, 2020	BUY	$3.0 - $5.52 $630,600 - $1.16 Million	210,200 New	210,200 $965,000
Q4 2019 Feb 13, 2020	SELL	$2.83 - $4.61 $112,917 - $183,939	-39,900 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$3.83 - $4.72 $152,817 - $188,328	39,900 New	39,900 $157,000

Others Institutions Holding CDXC

# of Institutions

Shares Held

17.2M

Call Options Held

66.7K

Put Options Held

8.2K

View Full List

About ChromaDex Corp.

Ticker CDXC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,350,896
Market Cap $510M
Description
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...

More about CDXC

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account